Skip to main content
TipRanks
Go Ultimate75% OFF

Immunotech Biopharm Ltd (6978) Income Statement

1 Followers

Immunotech Biopharm Ltd Income Statement

Last quarter (Q2 2026), Immunotech Biopharm Ltd's total revenue was ¥0.00. In Q2, Immunotech Biopharm Ltd's net income was ¥-68.90M. See Immunotech Biopharm Ltd’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
¥ -53.87M¥ 0.00¥ 0.00¥ 0.00¥ 0.00
¥ 115.49M¥ 198.78M¥ 230.55M¥ 273.93M¥ 344.86M
Depreciation and Amortization¥ 55.30M¥ 60.87M¥ 53.40M¥ 44.07M¥ 21.00M
¥ -168.80M¥ -140.03M¥ -177.65M¥ -230.15M¥ -324.33M
¥ -155.80M¥ -198.78M¥ -230.55M¥ -273.93M¥ -344.86M
¥ -75.11M¥ 12.36M¥ -104.93M¥ -47.16M¥ -9.75M
¥ -230.91M¥ -186.42M¥ -335.48M¥ -321.10M¥ -354.62M
¥ -230.78M¥ -186.91M¥ -334.82M¥ -318.11M¥ -354.22M
Per Share Metrics
Basic EPS¥ -0.42¥ -0.36¥ -0.65¥ -0.62¥ -0.69
Diluted EPS¥ -0.42¥ -0.36¥ -0.65¥ -0.62¥ -0.69
Weighted Average Shares Outstanding549.00M514.58M514.58M514.58M514.58M
Weighted Average Shares Outstanding (Diluted)549.00M514.58M514.58M514.58M514.58M

Currency in CNY

Immunotech Biopharm Ltd Earnings and Revenue History

-600M-400M-200M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin